Precision Optics Corporation, Inc. (POCI) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Precision Optics Corporation, Inc. (POCI) Healthcare & Pipeline Overview

Precision Optics Corporation, Inc. designs and manufactures specialized optical and illumination systems for the medical, industrial, and military sectors. Its product portfolio includes endoscopes, micro-precision lenses, and custom imaging solutions, positioning it as a niche player in the medical device and specialized optics market.

What Is the Investment Thesis for POCI?

Precision Optics Corporation, Inc. presents a focused investment opportunity within the specialized optics market. With a market capitalization of $48.7M, the company's financial performance reflects both challenges and opportunities. A negative profit margin of -28.3% indicates potential areas for operational improvement. A gross margin of 9.7% suggests competitive pricing pressures or high production costs. The company's beta of 0.33 suggests lower volatility compared to the broader market. Growth catalysts include expanding its product offerings in the medical device sector and securing additional contracts in the industrial and military sectors. Key risks involve managing operational costs and scaling production to meet demand.

Based on FMP financials and quantitative analysis

POCI Key Highlights

Market Cap of $48.7M indicates a micro-cap company with potential for high growth but also higher risk.

• Negative Profit Margin of -28.3% signals potential operational inefficiencies or pricing pressures that need to be addressed.
• Gross Margin of 9.7% suggests challenges in cost management or competitive pricing in its markets.
• Beta of 0.33 indicates lower volatility compared to the overall market, potentially appealing to risk-averse investors.
• No dividend yield reflects a focus on reinvesting earnings for growth rather than returning capital to shareholders.

Who Are POCI's Competitors?

POCI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are POCI's Key Strengths?

Specialized expertise in precision optics.

• Custom design and manufacturing capabilities.
• Established relationships with medical device companies.
• Diverse product portfolio serving multiple sectors.

What Are POCI's Weaknesses?

Small market capitalization limits financial flexibility.

• Negative profit margin indicates operational challenges.
• Limited brand recognition compared to larger competitors.
• High reliance on specific customer contracts.

What Could Drive POCI Stock Higher?

Potential new contracts in the industrial and military sectors could drive revenue growth.

• Increasing adoption of minimally invasive surgical procedures will drive demand for endoscopes and imaging systems.
• Strategic partnerships with medical device companies can expand market reach and product offerings.

What Are the Key Risks for POCI?

Financial-distress signal — its Altman Z-Score of 0.40 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-37.5%) — the business is not currently generating profit on shareholder capital.
• Intense competition from larger medical device manufacturers could pressure pricing and market share.
• Technological advancements may render existing products obsolete, requiring continuous innovation.
• Economic downturns could affect capital spending in healthcare and industrial sectors, impacting sales.
• The company's negative profit margin indicates operational challenges.

What Are the Growth Opportunities for POCI?

• Expansion in Minimally Invasive Surgical Instruments: The market for minimally invasive surgical instruments is projected to reach $45.8 billion by 2027, growing at a CAGR of 7.2%. Precision Optics can capitalize on this growth by developing advanced endoscopes and imaging systems that enhance surgical precision and patient outcomes. Focusing on specialized applications within this market can provide a competitive edge.
• Penetration of the Micro Medical Camera Market: The micro medical camera market is expected to experience significant growth due to the increasing demand for high-resolution imaging in diagnostic and surgical procedures. Precision Optics can leverage its expertise in micro-precision lenses to develop and market innovative micro camera solutions, targeting applications in endoscopy and robotic surgery.
• Increased Adoption of 3D Endoscopy: The adoption of 3D endoscopy is growing as surgeons seek improved depth perception and spatial orientation during minimally invasive procedures. Precision Optics can invest in the development of advanced 3D endoscopes, offering enhanced visualization and precision, thereby capturing a larger share of the market.
• Growth in Industrial and Military Applications: The demand for specialized optical components and assemblies in industrial and military applications is increasing, driven by advancements in automation, surveillance, and defense technologies. Precision Optics can expand its presence in these sectors by offering custom optical solutions for applications such as machine vision, remote sensing, and targeting systems.
• Strategic Partnerships with Medical Device Companies: Forming strategic partnerships with leading medical device companies can provide Precision Optics with access to established distribution networks and broader market reach. Collaborating on the development of integrated solutions can also enhance the company's product offerings and strengthen its competitive position.

What Are POCI's Competitive Advantages?

• Specialized Expertise: Deep knowledge in precision optics and custom solutions.
• Long-Standing Relationships: Established relationships with key customers in medical and industrial sectors.
• Proprietary Technology: Unique designs and manufacturing processes for specialized optical components.

What Does POCI Do?

Precision Optics Corporation, Inc., founded in 1982 and based in Gardner, Massachusetts, specializes in the design, development, manufacture, and sale of specialized optical and illumination systems and related components. The company primarily operates in the United States and the European Economic Area. Its core business revolves around medical instrumentation, offering products such as endoscopes, endocouplers, Microprecision lenses, micro medical cameras, and 3D endoscopes. These products are crucial for minimally invasive surgical procedures performed by hospitals and physicians. Beyond the medical field, Precision Optics also provides components and assemblies for industrial and military applications. The company markets its products directly to medical device companies, leveraging its expertise in precision optics to serve diverse sectors requiring specialized imaging and illumination solutions. Precision Optics has evolved into a key provider of custom optical solutions, focusing on high-precision components and systems.

What Products and Services Does POCI Offer?

• Designs and develops specialized optical systems.
• Manufactures precision lenses and optical components.
• Produces endoscopes and endocouplers for medical applications.
• Creates micro medical cameras for minimally invasive procedures.
• Offers custom imaging and illumination solutions.
• Provides optical components for industrial and military use.

How Does POCI Make Money?

• Designs and manufactures specialized optical and illumination systems.
• Sells products to medical device companies, industrial clients, and military contractors.
• Generates revenue through direct sales and custom development projects.

What Industry Does POCI Operate In?

Precision Optics Corporation, Inc. operates within the medical instruments and supplies industry, a segment characterized by continuous innovation and demand for minimally invasive surgical solutions. The market is driven by technological advancements in imaging and illumination, with a growing emphasis on precision and miniaturization. Competition includes larger medical device manufacturers and specialized optics companies. Precision Optics differentiates itself through its focus on custom solutions and specialized applications, catering to niche markets within the broader healthcare and industrial sectors.

Who Are POCI's Key Customers?

• Medical device companies requiring endoscopes and imaging systems.
• Hospitals and physicians using minimally invasive surgical procedures.
• Industrial clients needing optical components for automation and inspection.
• Military contractors requiring specialized optical systems for defense applications.

Over the past six months, Precision Optics Corporation, Inc. insiders filed 6 SEC Form 4 transactions — 0 sales and 6 purchases. On net that is roughly 117K shares acquired (about $459K) — insiders putting money in tends to read as conviction.

Quarterly Financial Performance: Precision Optics Corporation, Inc.

Revenue for Precision Optics Corporation, Inc. came in at $8.7M during Q3 FY2026, a 18.2% improvement versus the preceding quarter. The company recorded a net loss of $108K, with diluted EPS of $-0.01. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Healthcare company. Across the four most recent quarters, POCI averaged $-0.17 in diluted EPS.

POCI Valuation & Market Position

With a $48.7M market cap, Precision Optics Corporation, Inc. sits in the micro-cap segment of the market. Relative to its peer group, POCI's quantitative score of 32/100 is roughly in line with the peer average of 40/100.

Return on equity for Precision Optics Corporation, Inc. stands at -37.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -14.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -4.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.10 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -12.3%, the inverse of the P/E and a quick read on earnings relative to price.

Precision Optics Corporation, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.40 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Precision Optics Corporation, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Gardner, US. The company is led by CEO Joseph N. Forkey. POCI has traded publicly since 1992.

POCI Financials

POCI Latest News

POCI Analyst Consensus

POCI MoonshotScore

What Investors Ask About Precision Optics Corporation, Inc. (POCI) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources